Review Paper

NeuroMolecular Medicine

, Volume 10, Issue 4, pp 291-315

First online:

Mitochondrial Medicine for Aging and Neurodegenerative Diseases

  • P. Hemachandra ReddyAffiliated withNeurogenetics Laboratory, Neurological Sciences Institute, Oregon Health & Science University Email author 

Rent the article at a discount

Rent now

* Final gross prices may vary according to local VAT.

Get Access


Mitochondria are key cytoplasmic organelles, responsible for generating cellular energy, regulating intracellular calcium levels, altering the reduction-oxidation potential of cells, and regulating cell death. Increasing evidence suggests that mitochondria play a central role in aging and in neurodegenerative diseases, such as Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, amyotrophic lateral sclerosis, and Freidriech ataxia. Further, several lines of evidence suggest that mitochondrial dysfunction is an early event in most late-onset neurodegenerative diseases. Biochemical and animal model studies of inherited neurodegenerative diseases have revealed that mutant proteins of these diseases are associated with mitochondria. Mutant proteins are reported to block the transport of nuclear-encoded mitochondrial proteins to mitochondria, interact with mitochondrial proteins and disrupt the electron transport chain, induce free radicals, cause mitochondrial dysfunction, and, ultimately, damage neurons. This article discusses critical issues of mitochondria causing dysfunction in aging and neurodegenerative diseases, and discusses the potential of developing mitochondrial medicine, particularly mitochondrially targeted antioxidants, to treat aging and neurodegenerative diseases.


Amyloid beta Alzheimer's disease Amyotrophic lateral sclerosis Amyloid precursor protein Adenosine triphosphate Caloric restricted Electron transport chain FRDA Freidriech ataxia Hydrogen peroxide Huntington's disease Mitochondrial DNA Peroxisome proliferator activated receptor–coactivator Superoxide radical Oxidative phosphorylation Parkinson's disease Reactive oxygen species SS peptide